Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(2-chloro-4-(trifluoromethyl) Phenyl)-5, 7-dihydroxy-8-((2r, 3s)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4h-1-benzopyran-4-one
1. 1000023-04-0
2. Voruciclib [inn]
3. P1446a-05
4. W66xp666am
5. 2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2r,3s)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]chromen-4-one
6. Chembl3905910
7. 2-(2-chloro-4-(trifluoromethyl)phenyl)-5,7-dihydroxy-8-((2r,3s)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4h-1-benzopyran-4-one
8. 4h-1-benzopyran-4-one, 2-(2-chloro-4-(trifluoromethyl)phenyl)-5,7-dihydroxy-8-((2r,3s)-2-(hydroxymethyl)-1-methyl-3-pyrrolidinyl)-
9. Unii-w66xp666am
10. Voruciclib [who-dd]
11. Gtpl9923
12. Schembl3108205
13. Ex-a1056
14. Bdbm50193104
15. Nsc784284
16. P1446a
17. Db15157
18. Nsc-784284
19. Ncgc00387877-01
20. Ac-31553
21. As-82346
22. Hy-12422
23. Cs-0011273
24. Q27292377
25. 2-(2-chloro-4-(trifluoromethyl)phenyl)-5,7-dihydroxy-8-((2r,3s)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4h-chromen-4-one
26. 2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2r,3s)-2-(hydroxymethyl)-1-methyl-3-pyrrolidinyl]-4h-1-benzopyran-4-one
| Molecular Weight | 469.8 g/mol |
|---|---|
| Molecular Formula | C22H19ClF3NO5 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 469.0903849 g/mol |
| Monoisotopic Mass | 469.0903849 g/mol |
| Topological Polar Surface Area | 90.2 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 750 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Voruciclib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Voruciclib, including repackagers and relabelers. The FDA regulates Voruciclib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Voruciclib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Voruciclib supplier is an individual or a company that provides Voruciclib active pharmaceutical ingredient (API) or Voruciclib finished formulations upon request. The Voruciclib suppliers may include Voruciclib API manufacturers, exporters, distributors and traders.
Voruciclib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Voruciclib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Voruciclib GMP manufacturer or Voruciclib GMP API supplier for your needs.
A Voruciclib CoA (Certificate of Analysis) is a formal document that attests to Voruciclib's compliance with Voruciclib specifications and serves as a tool for batch-level quality control.
Voruciclib CoA mostly includes findings from lab analyses of a specific batch. For each Voruciclib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Voruciclib may be tested according to a variety of international standards, such as European Pharmacopoeia (Voruciclib EP), Voruciclib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Voruciclib USP).
LOOKING FOR A SUPPLIER?
